RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)
Clinical trial NCT04193696 · UNKNOWN
Trial details
- NCT number
- NCT04193696
- Sponsor
- Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-10
- Primary completion
- 2020-06-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.